Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Michael Clay

Concepts (316)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lipoma
4
2022
17
1.770
 Why?
Biomarkers, Tumor
10
2024
1321
1.720
 Why?
Soft Tissue Neoplasms
5
2024
128
1.190
 Why?
Proto-Oncogene Proteins c-mdm2
4
2024
67
1.170
 Why?
Liposarcoma
4
2024
31
1.070
 Why?
Rhabdomyosarcoma
4
2022
64
1.000
 Why?
Adrenal Cortex Neoplasms
3
2023
69
0.970
 Why?
In Situ Hybridization, Fluorescence
5
2024
324
0.910
 Why?
Adrenocortical Carcinoma
2
2023
71
0.850
 Why?
DNA Methylation
5
2024
667
0.830
 Why?
Carcinoma, Intraductal, Noninfiltrating
2
2013
61
0.750
 Why?
Carcinoma, Ductal, Breast
2
2013
89
0.740
 Why?
Tissue Scaffolds
1
2024
223
0.720
 Why?
Surgical Wound Infection
1
2024
330
0.670
 Why?
Immunohistochemistry
7
2024
1710
0.660
 Why?
Extracellular Matrix
1
2024
562
0.630
 Why?
Fibroma
1
2020
20
0.620
 Why?
Gene Expression Regulation, Neoplastic
5
2021
1439
0.580
 Why?
Succinate Dehydrogenase
1
2019
66
0.580
 Why?
Gastrointestinal Stromal Tumors
1
2019
41
0.570
 Why?
Gastrointestinal Neoplasms
1
2019
71
0.560
 Why?
Gene Expression Profiling
4
2025
1769
0.500
 Why?
Kidney Neoplasms
4
2024
416
0.500
 Why?
Breast Neoplasms
3
2014
2373
0.490
 Why?
Cyclin-Dependent Kinase 4
1
2016
53
0.480
 Why?
Gene Amplification
2
2020
120
0.480
 Why?
DNA Mismatch Repair
1
2014
53
0.420
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2014
40
0.410
 Why?
Neoplasms, Second Primary
1
2014
102
0.390
 Why?
Receptor, Notch1
1
2013
63
0.390
 Why?
Tumor Suppressor Protein p53
4
2023
536
0.390
 Why?
Diagnosis, Differential
6
2024
1507
0.390
 Why?
Translocation, Genetic
1
2013
119
0.380
 Why?
Microtubule-Associated Proteins
1
2013
197
0.370
 Why?
Wilms Tumor
3
2023
88
0.350
 Why?
Sexually Transmitted Diseases, Viral
1
2010
11
0.320
 Why?
Lymphangioleiomyomatosis
1
2011
37
0.320
 Why?
Myometrium
1
2011
38
0.320
 Why?
Li-Fraumeni Syndrome
2
2021
15
0.320
 Why?
Anus Neoplasms
1
2010
32
0.310
 Why?
Nuclear Proteins
4
2021
743
0.310
 Why?
Uterine Neoplasms
1
2011
96
0.310
 Why?
Humans
45
2026
145491
0.280
 Why?
Germ-Line Mutation
2
2021
176
0.280
 Why?
Male
29
2026
72817
0.250
 Why?
Genomics
3
2021
834
0.250
 Why?
Child, Preschool
11
2026
11837
0.240
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2020
1965
0.230
 Why?
Female
28
2026
78763
0.230
 Why?
Child, Hospitalized
1
2026
54
0.230
 Why?
Oncogene Proteins, Fusion
2
2024
212
0.220
 Why?
Arthritis, Juvenile
1
2025
60
0.220
 Why?
Myoepithelioma
1
2024
3
0.220
 Why?
Hyphae
1
2024
11
0.220
 Why?
Synovial Membrane
1
2025
124
0.210
 Why?
Epigenesis, Genetic
3
2024
672
0.210
 Why?
Neoplasms
4
2021
2897
0.210
 Why?
Child
17
2026
22680
0.200
 Why?
Adamantinoma
1
2023
4
0.200
 Why?
Young Adult
8
2024
14192
0.200
 Why?
Oncogene Fusion
2
2020
11
0.200
 Why?
Adult
16
2026
40707
0.200
 Why?
Antineoplastic Agents
3
2023
2207
0.190
 Why?
Adolescent
11
2026
22485
0.190
 Why?
X-linked Nuclear Protein
2
2020
8
0.190
 Why?
Fungi
1
2024
161
0.190
 Why?
Meniscus
1
2023
23
0.190
 Why?
Rhabdomyosarcoma, Embryonal
1
2022
16
0.180
 Why?
Wound Healing
1
2024
355
0.180
 Why?
Liver Neoplasms
2
2019
779
0.170
 Why?
Neuroblastoma
2
2020
174
0.170
 Why?
Infant
10
2021
10064
0.170
 Why?
Immunoglobulin A
1
2022
214
0.170
 Why?
In Situ Hybridization
1
2021
318
0.170
 Why?
Penetrance
1
2021
30
0.170
 Why?
Bone Neoplasms
1
2023
256
0.170
 Why?
Mutation
4
2021
4093
0.170
 Why?
Orthopedic Procedures
1
2023
243
0.160
 Why?
Aged, 80 and over
5
2024
8326
0.160
 Why?
Myofibroma
1
2020
3
0.160
 Why?
Germ Cells
1
2021
65
0.160
 Why?
DNA Copy Number Variations
1
2021
184
0.160
 Why?
Xanthogranuloma, Juvenile
1
2020
6
0.160
 Why?
Xenograft Model Antitumor Assays
3
2019
929
0.160
 Why?
Introns
1
2021
256
0.160
 Why?
Middle Aged
11
2024
36176
0.160
 Why?
Whole Genome Sequencing
1
2021
184
0.160
 Why?
Tandem Repeat Sequences
2
2017
23
0.160
 Why?
Anterior Cruciate Ligament Injuries
1
2023
218
0.160
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2020
31
0.160
 Why?
Exons
1
2021
363
0.160
 Why?
Neoplasm Recurrence, Local
3
2022
1150
0.160
 Why?
N-Myc Proto-Oncogene Protein
1
2020
11
0.160
 Why?
Sarcoma, Ewing
1
2021
103
0.160
 Why?
Receptor, trkA
1
2020
18
0.160
 Why?
Ubiquitin Thiolesterase
1
2020
68
0.160
 Why?
Aged
8
2024
26125
0.150
 Why?
Lamin Type A
1
2020
50
0.150
 Why?
Disease Susceptibility
1
2021
343
0.150
 Why?
Phthalazines
1
2020
63
0.150
 Why?
Osteoarthritis, Knee
1
2023
280
0.150
 Why?
Computational Biology
2
2021
687
0.150
 Why?
Phenotype
2
2020
3157
0.150
 Why?
Cell Nucleus
2
2020
593
0.150
 Why?
Clonal Evolution
1
2019
47
0.150
 Why?
Cell Dedifferentiation
1
2019
32
0.150
 Why?
Narcotics
1
2019
58
0.150
 Why?
Office Visits
1
2019
92
0.150
 Why?
Mental Health
1
2026
795
0.150
 Why?
Transcriptome
1
2025
1038
0.140
 Why?
Mutation, Missense
1
2021
338
0.140
 Why?
Muscle Neoplasms
1
2018
9
0.140
 Why?
Psychomotor Disorders
1
2018
15
0.140
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2020
132
0.140
 Why?
DNA Damage
1
2021
434
0.140
 Why?
Scrotum
1
2018
25
0.140
 Why?
Patella
1
2018
28
0.140
 Why?
Rhabdoid Tumor
1
2019
102
0.140
 Why?
Anxiety
1
2026
1127
0.140
 Why?
Protein-Tyrosine Kinases
2
2018
431
0.140
 Why?
Codon, Nonsense
1
2018
44
0.140
 Why?
ErbB Receptors
2
2022
635
0.140
 Why?
Arthroplasty, Replacement, Knee
1
2023
372
0.130
 Why?
Neuroendocrine Tumors
1
2019
119
0.130
 Why?
Immunophenotyping
1
2019
320
0.130
 Why?
Craniofacial Abnormalities
1
2018
78
0.130
 Why?
Histone Acetyltransferases
1
2018
57
0.130
 Why?
Health Expenditures
1
2019
194
0.130
 Why?
Tumor Burden
2
2017
324
0.130
 Why?
Urogenital Abnormalities
1
2018
71
0.130
 Why?
Prognosis
3
2022
4323
0.130
 Why?
Fused Kidney
1
2017
1
0.130
 Why?
Heterozygote
1
2018
313
0.130
 Why?
Mice
8
2022
18338
0.130
 Why?
Arthritis, Rheumatoid
2
2025
1177
0.130
 Why?
Proto-Oncogene Proteins c-bcl-6
1
2017
11
0.130
 Why?
Cell Cycle Proteins
2
2018
631
0.130
 Why?
Sarcoma, Clear Cell
1
2017
10
0.130
 Why?
Fibrosarcoma
1
2017
23
0.130
 Why?
Drug Prescriptions
1
2019
287
0.130
 Why?
Parents
1
2026
1404
0.130
 Why?
Beckwith-Wiedemann Syndrome
1
2016
7
0.130
 Why?
Opiate Substitution Treatment
1
2019
186
0.120
 Why?
Single-Cell Analysis
1
2020
359
0.120
 Why?
Insurance, Health
1
2019
308
0.120
 Why?
Hemangioendothelioma
1
2016
13
0.120
 Why?
Intellectual Disability
1
2018
178
0.120
 Why?
Kasabach-Merritt Syndrome
1
2016
8
0.120
 Why?
Ectodermal Dysplasia
1
2016
20
0.120
 Why?
Genetic Variation
1
2021
988
0.120
 Why?
Scalp
1
2016
38
0.120
 Why?
Depression
1
2026
1573
0.120
 Why?
Reproducibility of Results
2
2015
3424
0.120
 Why?
Retrospective Studies
6
2024
17269
0.120
 Why?
Troponin
1
2015
50
0.120
 Why?
Buprenorphine
1
2019
190
0.110
 Why?
Sarcoma, Kaposi
1
2016
83
0.110
 Why?
Hospitalization
1
2026
2458
0.110
 Why?
Mismatch Repair Endonuclease PMS2
1
2014
4
0.110
 Why?
MutL Protein Homolog 1
1
2014
11
0.110
 Why?
MutS Homolog 2 Protein
1
2014
12
0.110
 Why?
Clone Cells
2
2017
264
0.110
 Why?
Chromosome Aberrations
2
2017
164
0.110
 Why?
DNA Repair Enzymes
1
2014
29
0.110
 Why?
Genetic Predisposition to Disease
3
2021
2355
0.100
 Why?
Drug Resistance, Neoplasm
1
2019
881
0.100
 Why?
Adenosine Triphosphatases
1
2014
161
0.100
 Why?
Repressor Proteins
1
2017
430
0.100
 Why?
Proto-Oncogene Proteins
1
2017
620
0.100
 Why?
DNA Mutational Analysis
1
2014
409
0.100
 Why?
Predictive Value of Tests
2
2017
2129
0.100
 Why?
Breast
1
2013
157
0.090
 Why?
Proto-Oncogene Proteins B-raf
1
2014
224
0.090
 Why?
Trastuzumab
1
2013
117
0.090
 Why?
Algorithms
1
2020
1855
0.090
 Why?
Sensitivity and Specificity
1
2016
2002
0.090
 Why?
Adaptor Proteins, Signal Transducing
1
2014
426
0.090
 Why?
Stromal Cells
2
2025
120
0.090
 Why?
Disease Management
1
2015
654
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2019
994
0.080
 Why?
Mastectomy
1
2013
181
0.080
 Why?
Epithelioid Cells
1
2011
9
0.080
 Why?
Opioid-Related Disorders
1
2019
601
0.080
 Why?
Genomic Imprinting
2
2023
26
0.080
 Why?
Penile Neoplasms
1
2010
7
0.080
 Why?
Risk Factors
2
2015
10874
0.080
 Why?
Uterine Cervical Dysplasia
1
2010
27
0.080
 Why?
Kidney
1
2018
1498
0.080
 Why?
Disease Models, Animal
1
2021
4559
0.080
 Why?
Animals
10
2023
38141
0.080
 Why?
DNA, Neoplasm
1
2010
158
0.080
 Why?
Brain Neoplasms
1
2019
1329
0.080
 Why?
Papillomaviridae
1
2010
116
0.080
 Why?
Combined Modality Therapy
1
2013
1269
0.080
 Why?
Mice, Nude
2
2021
678
0.070
 Why?
Critical Illness
1
2015
901
0.070
 Why?
Neoplasm Staging
1
2013
1468
0.070
 Why?
Sequence Analysis, RNA
2
2021
443
0.070
 Why?
Prospective Studies
2
2026
8039
0.070
 Why?
Liver
1
2016
1895
0.070
 Why?
Fibroblasts
2
2025
1023
0.070
 Why?
Tomography, X-Ray Computed
1
2018
2772
0.070
 Why?
DNA-Binding Proteins
1
2014
1487
0.060
 Why?
Uterine Cervical Neoplasms
1
2010
269
0.060
 Why?
Databases, Factual
1
2013
1500
0.060
 Why?
Receptor, Notch3
1
2025
8
0.060
 Why?
Chemokine CXCL13
1
2025
15
0.060
 Why?
DNA
2
2023
1451
0.060
 Why?
Receptors, CXCR3
1
2025
17
0.060
 Why?
Receptors, CXCR5
1
2025
27
0.060
 Why?
Rodent Control
1
1985
2
0.060
 Why?
Leptospira interrogans
1
1985
4
0.060
 Why?
Chemokine CXCL9
1
2025
38
0.060
 Why?
Leptospirosis
1
1985
8
0.060
 Why?
Chemokine CXCL12
1
2025
86
0.060
 Why?
Carcinoma, Squamous Cell
1
2010
644
0.060
 Why?
Signal Transduction
3
2025
5202
0.050
 Why?
Gene Fusion
1
2024
30
0.050
 Why?
Diaphyses
1
2023
10
0.050
 Why?
Ulna
1
2023
35
0.050
 Why?
Occupational Diseases
1
1985
165
0.050
 Why?
Activating Transcription Factor 4
1
2023
22
0.050
 Why?
Proteasome Inhibitors
1
2023
38
0.050
 Why?
Fibula
1
2023
36
0.050
 Why?
Adenocarcinoma
1
2010
923
0.050
 Why?
Proteasome Endopeptidase Complex
1
2023
153
0.050
 Why?
Imidazoles
1
2023
246
0.040
 Why?
Drug Resistance
1
2022
146
0.040
 Why?
Carcinoma, Renal Cell
1
2024
234
0.040
 Why?
Muscle Development
1
2022
113
0.040
 Why?
Gene Knock-In Techniques
1
2021
61
0.040
 Why?
Myositis Ossificans
1
2020
4
0.040
 Why?
Periosteum
1
2020
14
0.040
 Why?
Cellular Senescence
1
2023
225
0.040
 Why?
Fasciitis
1
2020
11
0.040
 Why?
Piperazines
1
2023
378
0.040
 Why?
Brazil
1
2021
183
0.040
 Why?
Biopsy
1
2024
1081
0.040
 Why?
Dasatinib
1
2020
57
0.040
 Why?
Freezing
1
2020
86
0.040
 Why?
Complement Activation
1
2023
409
0.040
 Why?
Autoantigens
1
2022
426
0.040
 Why?
Gene Rearrangement
1
2020
156
0.040
 Why?
CD8-Positive T-Lymphocytes
1
2025
917
0.040
 Why?
Etoposide
1
2019
168
0.040
 Why?
Carboplatin
1
2019
161
0.040
 Why?
Receptors, Immunologic
1
2020
206
0.040
 Why?
Mice, SCID
1
2019
369
0.040
 Why?
Organophosphorus Compounds
1
2019
84
0.040
 Why?
Prevalence
1
2026
2855
0.040
 Why?
Neoplasm Grading
1
2019
311
0.040
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
44
0.040
 Why?
Genotype
1
2023
1853
0.040
 Why?
Tumor Microenvironment
1
2023
737
0.040
 Why?
Tumor Cells, Cultured
1
2020
883
0.030
 Why?
Unfolded Protein Response
1
2018
58
0.030
 Why?
Longitudinal Studies
1
2026
2950
0.030
 Why?
Immunoglobulin G
1
2022
890
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p57
1
2017
5
0.030
 Why?
Epigenomics
1
2018
112
0.030
 Why?
Macrophages
1
2025
1509
0.030
 Why?
Chromosomes, Human, Pair 11
1
2017
59
0.030
 Why?
Genes, p53
1
2017
67
0.030
 Why?
Bortezomib
1
2017
54
0.030
 Why?
Membrane Glycoproteins
1
2020
496
0.030
 Why?
Infant, Newborn
2
2021
6437
0.030
 Why?
Hydroxamic Acids
1
2017
94
0.030
 Why?
Cohort Studies
2
2020
5992
0.030
 Why?
Heterografts
1
2017
143
0.030
 Why?
Reactive Oxygen Species
1
2020
602
0.030
 Why?
Vincristine
1
2017
140
0.030
 Why?
Camptothecin
1
2017
138
0.030
 Why?
Pyrimidinones
1
2017
125
0.030
 Why?
Mice, Transgenic
1
2021
2189
0.030
 Why?
High-Throughput Screening Assays
1
2017
177
0.030
 Why?
Family
1
2020
687
0.030
 Why?
beta Catenin
1
2017
253
0.030
 Why?
Molecular Targeted Therapy
1
2018
439
0.030
 Why?
Antibodies, Monoclonal
1
2022
1511
0.030
 Why?
Medicaid
1
2019
466
0.030
 Why?
Autoantibodies
1
2022
1512
0.030
 Why?
Apoptosis
1
2023
2411
0.030
 Why?
Drug Therapy, Combination
1
2017
1046
0.030
 Why?
Leukocyte Transfusion
1
1994
5
0.030
 Why?
Precision Medicine
1
2018
456
0.030
 Why?
Granulocytes
1
1994
81
0.030
 Why?
Polymerase Chain Reaction
1
2017
1049
0.030
 Why?
Pyrimidines
1
2017
520
0.020
 Why?
Medicare
1
2019
905
0.020
 Why?
Indoles
1
2017
508
0.020
 Why?
Pyrazoles
1
2017
517
0.020
 Why?
Cells, Cultured
1
2021
4127
0.020
 Why?
Mycoses
1
1994
88
0.020
 Why?
Neutropenia
1
1994
155
0.020
 Why?
Mitochondria
1
2020
990
0.020
 Why?
Mice, Knockout
1
2020
3125
0.020
 Why?
Bone Marrow Transplantation
1
1994
297
0.020
 Why?
Healthcare Disparities
1
2019
739
0.020
 Why?
Aging
1
2023
1940
0.020
 Why?
Acute Coronary Syndrome
1
2015
297
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2015
442
0.020
 Why?
Proteomics
1
2018
1191
0.020
 Why?
United States Department of Veterans Affairs
1
2015
775
0.020
 Why?
Hospital Mortality
1
2015
1044
0.020
 Why?
Cell Line, Tumor
1
2018
3537
0.020
 Why?
Mice, Inbred C57BL
1
2021
5989
0.020
 Why?
United States
2
2019
16115
0.020
 Why?
Registries
1
2017
2410
0.020
 Why?
Epidemiologic Methods
1
1985
91
0.010
 Why?
Michigan
1
1985
138
0.010
 Why?
Treatment Outcome
1
2019
11831
0.010
 Why?
Biomarkers
1
2015
4283
0.010
 Why?
Rats
1
1985
5581
0.010
 Why?
Aspergillus
1
1994
18
0.010
 Why?
Candidiasis
1
1994
64
0.010
 Why?
Candida albicans
1
1994
61
0.010
 Why?
Clay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (316) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)